首页 › 基金 › Blue Water Life Science Advisors, LP › CDNA

Blue Water Life Science Advisors, LP 对 CDNA 的持仓历史

CAREDX INC · 医疗保健

Blue Water Life Science Advisors, LP 在 Q3 2026 的 13F 申报中披露持有 CDNA(CAREDX INC)1,740,000 股,市值约 US$113.1M,约占其申报组合的 44.96%,在其申报持仓中市值排名第 1 位。 Blue Water Life Science Advisors, LP 最近 10 个申报季度中有 10 个季度披露了 CDNA 持仓,最早可追溯至 Q2 2024。

最新持仓 (Q3 2026)1.74M 股
申报持仓市值$113.10M
组合权重44.96%
首次申报Q2 2024
最近变动增持
更新于2026-11-14

最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR

Blue Water Life Science Advisors, LP 对 CDNA 的持仓演变

Blue Water Life Science Advisors, LP 于 Q2 2024 首次披露 CDNA 持仓:510,000 股(约 US$7.9M)。 该持仓在 Q3 2026 达到峰值 1,740,000 股,市值约 US$113.1M。 在 10 次申报中,Blue Water Life Science Advisors, LP 5 次增持、1 次减持、3 次保持不变。 最近一期申报(Q3 2026)显示持股 1,740,000 股、市值约 US$113.1M,环比增持 550,000 股。。 持仓曾出现大幅变动:Q3 2025 减持约 30% (随后一个季度股价上涨 30%)、Q1 2026 增持约 83% (随后一个季度股价上涨 64%)、Q3 2026 增持约 46% (随后一个季度股价上涨 20%)。

逐季持仓明细

季度股数金额变化
Q2 2024 510.00K $7.92M 新进
Q3 2024 604.00K $18.86M 增持
Q4 2024 604.00K $12.93M 持有
Q1 2025 724.01K $12.85M 增持
Q2 2025 724.01K $14.15M 持有
Q3 2025 510.00K $7.42M 减持
Q4 2025 510.00K $9.61M 持有
Q1 2026 935.00K $16.23M 增持
Q2 2026 1.19M $33.91M 增持
Q3 2026 1.74M $113.10M 增持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 CDNA 与 13F 数据

CDNA(CAREDX INC)属于医疗保健行业。我们追踪的基金中还有 47 只申报持有 CDNA,申报仓位最大的包括:方舟投资 (US$104.6M), GAGNON SECURITIES LLC (US$69.8M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$56.9M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 CDNA 的基金

查看 CDNA 的全部基金持有人 →

常见问题

How long has Blue Water Life Science Advisors, LP held CDNA?

Blue Water Life Science Advisors, LP has disclosed CDNA holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

What is Blue Water Life Science Advisors, LP's current position in CDNA?

As of Q3 2026, Blue Water Life Science Advisors, LP holds 1.74M shares of CDNA (CAREDX INC), valued at $113.10M, representing 44.96% of its reported portfolio and ranking #1.

Has Blue Water Life Science Advisors, LP been buying or selling CDNA?

In the latest 13F filing (Q3 2026), Blue Water Life Science Advisors, LP increased its position in CDNA. The position peaked in Q3 2026 at 1.74M shares.

Which other funds hold CDNA?

Other major institutional holders of CDNA include 方舟投资, GAGNON SECURITIES LLC, DEERFIELD MANAGEMENT COMPANY, L.P., among 47 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.